Special requirements for hormone releasing intrauterine devices.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D001702:Biopharmaceutics; D002986:Clinical Trials as Topic; D003270:Contraceptive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D005298:Fertility / Q000187:drug effects; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects*; D008722:Methods; D011108:Polymers; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D013997:Time Factors; D014592:Uterine Hemorrhage / Q000209:etiology; D014599:Uterus / Q000187:drug effects
D003270:Contraceptive Agents; D003692:Delayed-Action Preparations; D011108:Polymers; D011374:Progesterone